Ahrb-1/Ahrb-1
C57BL/6J
|
normal
homeostasis/metabolism phenotype |
J:5387
|
|
increased inflammatory response |
J:5244,
J:5387
|
|
increased physiological sensitivity to xenobiotic |
J:26440,
J:113285,
J:132380
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:26440,
J:113285
|
Ahrb-1/Ahrb-1
C58/J
|
increased physiological sensitivity to xenobiotic |
J:26440
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrb-1/Ahrb-1
involves: C57BL/6J * DBA/2J
|
abnormal immune system physiology |
J:5387
|
|
normal
homeostasis/metabolism phenotype |
J:5387
|
Ahrb-1/Ahrd
involves: 129S1/SvImJ * C57BL/6J
|
increased incidence of tumors by chemical induction |
J:113356
|
|
increased physiological sensitivity to xenobiotic |
J:113356
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:113356
|
Ahrb-1/Ahrd
involves: C57BL/6 * DBA/2
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:113285
|
Ahrb-2/Ahrb-2
A/He
|
increased physiological sensitivity to xenobiotic |
J:26440
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrb-2/Ahrb-2
C3H/He
|
increased physiological sensitivity to xenobiotic |
J:26440
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrb-3/Ahrb-3
M. spretus
|
normal
homeostasis/metabolism phenotype |
J:22144,
J:34840
|
Ahrd/Ahrd
AKR
|
decreased physiological sensitivity to xenobiotic |
J:26440
|
|
decreased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrd/Ahrd
B6.D2-Ahrd
|
decreased physiological sensitivity to xenobiotic |
J:113285
|
|
decreased susceptibility to xenobiotic induced morbidity/mortality |
J:113285
|
Ahrd/Ahrd
DBA/2
|
decreased physiological sensitivity to xenobiotic |
J:26440
|
|
decreased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrd/Ahrd
DBA/2J
|
decreased physiological sensitivity to xenobiotic |
J:26440,
J:132380
|
|
decreased susceptibility to xenobiotic induced morbidity/mortality |
J:26440
|
Ahrd/Ahrd
involves: 129S1/SvImJ * C57BL/6J
|
increased incidence of tumors by chemical induction |
J:113356
|
|
increased physiological sensitivity to xenobiotic |
J:113356
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:113356
|
Ahrtm1.2Arte/Ahrtm1.2Arte
involves: C57BL/6NTac
|
abnormal cauda epididymis morphology |
J:210360
|
|
abnormal male germ cell apoptosis |
J:210360
|
|
abnormal seminiferous tubule epithelium morphology |
J:210360
|
|
abnormal sperm head morphology |
J:210360
|
|
abnormal spermiation |
J:210360
|
|
coiled sperm flagellum |
J:210360
|
|
decreased epididymis weight |
J:210360
|
|
decreased fertilization frequency |
J:210360
|
|
decreased testis weight |
J:210360
|
|
multinucleated giant male germ cells |
J:210360
|
|
seminiferous tubule degeneration |
J:210360
|
|
teratozoospermia |
J:210360
|
Ahrtm1Bra/Ahrtm1Bra
B6.129-Ahrtm1Bra
|
abnormal circulating hormone level |
J:126176
|
|
abnormal eye vasculature morphology |
J:64483
|
|
abnormal hepatocyte morphology |
J:64483
|
|
abnormal kidney vasculature morphology |
J:64483
|
|
abnormal liver sinusoid morphology |
J:64483
|
|
decreased liver weight |
J:64483
|
|
decreased physiological sensitivity to xenobiotic |
J:126176
|
|
decreased prostate gland anterior lobe weight |
J:126176
|
|
decreased prostate gland dorsolateral lobe weight |
J:126176
|
|
decreased seminal vesicle weight |
J:126176
|
|
increased body weight |
J:126176
|
|
patent ductus venosus |
J:64483
|
|
persistent hyaloid artery |
J:64483
|
Ahrtm1Bra/Ahrtm1Bra
B6.129-Ahrtm1Bra/J
|
abnormal chemokine level |
J:118646
|
|
abnormal cytokine level |
J:118646
|
|
abnormal enzyme/coenzyme activity |
J:100359
|
|
abnormal interleukin level |
J:118646
|
|
abnormal macrophage physiology |
J:118646
|
|
abnormal ovary physiology |
J:59155
|
|
abnormal tumor necrosis factor level |
J:118646
|
|
increased physiological sensitivity to xenobiotic |
J:118646
|
|
increased primordial ovarian follicle number |
J:59155
|
|
increased susceptibility to bacterial infection |
J:118646
|
|
increased susceptibility to injury |
J:100359
|
|
lung inflammation |
J:100359,
J:118646
|
|
pulmonary alveolar edema |
J:100359
|
|
pulmonary edema |
J:100359
|
Ahrtm1Bra/Ahrtm1Bra
involves: 129S1/Sv * 129X1/SvJ
|
abnormal branching of the mammary ductal tree |
J:51158
|
|
abnormal ovarian folliculogenesis |
J:82983
|
|
abnormal ovary physiology |
J:124374
|
|
abnormal ovulation |
J:82983
|
|
decreased corpora lutea number |
J:83527
|
|
decreased germ cell number |
J:83527
|
|
decreased ovary weight |
J:124374
|
|
decreased secondary ovarian follicle number |
J:82983,
J:83527
|
|
decreased superovulation rate |
J:124374
|
|
decreased tertiary ovarian follicle number |
J:82983,
J:83527
|
|
increased primordial ovarian follicle number |
J:83527
|
|
patent ductus venosus |
J:94465,
J:166864
|
|
small ovary |
J:82983
|
Ahrtm1Bra/Ahrtm1Bra
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal cytokine secretion |
J:148870
|
|
abnormal keratinocyte physiology |
J:148870
|
|
abnormal Langerhans cell morphology |
J:148870
|
|
abnormal Langerhans cell physiology |
J:148870
|
|
decreased body weight |
J:33827
|
|
decreased liver weight |
J:83597
|
|
decreased physiological sensitivity to xenobiotic |
J:83597
|
|
decreased spleen germinal center size |
J:33827
|
|
decreased susceptibility to type IV hypersensitivity reaction |
J:148870
|
|
enlarged spleen |
J:33827
|
|
extramedullary hematopoiesis |
J:33827
|
|
increased primordial ovarian follicle number |
J:59155
|
|
liver hyperplasia |
J:33827
|
|
microvesicular hepatic steatosis |
J:33827
|
|
pale liver |
J:33827
|
|
patent ductus venosus |
J:83597
|
|
postnatal growth retardation |
J:33827
|
|
small liver |
J:33827
|
Ahrtm1Gonz/Ahrtm1Gonz
involves: 129S4/SvJae
|
decreased physiological sensitivity to xenobiotic |
J:36360
|
|
normal
reproductive system phenotype |
J:76280
|
Ahrtm1Gonz/Ahrtm1Gonz
involves: 129S4/SvJae * C57BL/6J
|
decreased litter size |
J:113285
|
|
decreased physiological sensitivity to xenobiotic |
J:113285
|
|
decreased susceptibility to xenobiotic induced morbidity/mortality |
J:113285
|
Ahrtm1Gonz/Ahrtm1Gonz
involves: 129S4/SvJae * C57BL/6N
|
abnormal atrial thrombosis |
J:44690
|
|
abnormal auchene hair morphology |
J:44690
|
|
abnormal blood vessel morphology |
J:44690
|
|
abnormal coat/ hair morphology |
J:44690
|
|
abnormal colon morphology |
J:44690
|
|
abnormal coronary artery morphology |
J:44690
|
|
abnormal epidermal layer morphology |
J:44690
|
|
abnormal hair follicle morphology |
J:44690
|
|
abnormal hair shaft morphology |
J:44690
|
|
abnormal heart morphology |
J:44690
|
|
abnormal hepatocyte morphology |
J:25048,
J:44690
|
|
abnormal liver morphology |
J:25048,
J:44690
|
|
abnormal liver physiology |
J:25048
|
|
abnormal skin condition |
J:44690
|
|
abnormal spleen morphology |
J:44690
|
|
abnormal spleen red pulp morphology |
J:44690
|
|
abnormal stomach pyloric region morphology |
J:44690
|
|
abnormal thrombosis |
J:44690
|
|
abnormal uterus morphology |
J:44690
|
|
acanthosis |
J:44690
|
|
alopecia |
J:44690
|
|
bile duct inflammation |
J:25048
|
|
cardiac fibrosis |
J:44690
|
|
chronic diarrhea |
J:44690
|
|
colitis |
J:44690
|
|
decreased litter size |
J:44690
|
|
decreased liver weight |
J:25048
|
|
decreased physiological sensitivity to xenobiotic |
J:25048
|
|
decreased spleen white pulp amount |
J:44690
|
|
dilated piliary canal |
J:44690
|
|
enlarged heart |
J:44690
|
|
enlarged spleen |
J:44690
|
|
folliculitis |
J:44690
|
|
gastric polyps |
J:44690
|
|
heart inflammation |
J:44690
|
|
hypergranulosis |
J:44690
|
|
increased heart weight |
J:44690
|
|
increased hepatoma incidence |
J:44690
|
|
increased inflammatory response |
J:25048
|
|
increased liver adenoma incidence |
J:44690
|
|
liver fibrosis |
J:25048,
J:44690
|
|
postnatal growth retardation |
J:25048
|
|
postnatal lethality, incomplete penetrance |
J:25048
|
|
premature death |
J:44690
|
|
rectal prolapse |
J:44690
|
|
reduced female fertility |
J:44690
|
|
scaly skin |
J:44690
|
|
skin lesions |
J:44690
|
|
small spleen |
J:25048
|
|
spleen hypoplasia |
J:25048
|
|
spontaneous skin ulceration |
J:44690
|
|
thick skin |
J:44690
|
|
vascular smooth muscle hypertrophy |
J:44690
|
|
weight loss |
J:44690
|
Ahrtm1Yfk/Ahrtm1Yfk
involves: 129S/SvEv * C57BL/6J
|
abnormal horizontal vestibuloocular reflex |
J:195817
|
|
abnormal optokinetic reflex |
J:195817
|
|
abnormal urinary bladder morphology |
J:179919
|
|
abnormal urinary bladder urothelium morphology |
J:179919
|
|
abnormal urinary bladder vasculature morphology |
J:179919
|
|
abnormal xenobiotic pharmacokinetics |
J:82937
|
|
cystolithiasis |
J:179919
|
|
decreased physiological sensitivity to xenobiotic |
J:46346
|
|
disorganized retina layers |
J:195817
|
|
normal
homeostasis/metabolism phenotype |
J:179919
|
|
increased urinary bladder carcinoma incidence |
J:179919
|
|
increased urine uric acid level |
J:179919
|
|
normal
nervous system phenotype |
J:195817
|
|
postnatal growth retardation |
J:46346
|
|
normal
renal/urinary system phenotype |
J:179919
|
|
normal
skeleton phenotype |
J:179919
|
|
urinary bladder fibrosis |
J:179919
|
|
urinary bladder inflammation |
J:179919
|
Ahrtm2Bra/Ahrtm2Bra
involves: 129/Sv * C57BL/6
|
decreased liver weight |
J:83597
|
|
decreased physiological sensitivity to xenobiotic |
J:83597
|
|
increased heart weight |
J:83597
|
|
increased spleen weight |
J:83597
|
|
patent ductus venosus |
J:83597
|
Ahrtm3.1Bra/Ahrtm3.1Bra
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
B6.Cg-Ahrtm3.1Bra Speer6-ps1Tg(Alb-cre)21Mgn
|
normal
cardiovascular system phenotype |
J:104388
|
|
decreased physiological sensitivity to xenobiotic |
J:104388
|
Ahrtm3.1Bra/Ahrtm3.1Bra
Tg(Nes-cre)1Kln/0
involves: 129/Sv * C57BL/6 * SJL
|
abnormal glial cell morphology |
J:292713
|
|
decreased susceptibility to ischemic brain injury |
J:292713
|
|
increased neuronal precursor cell number |
J:292713
|
Ahrtm3.1Bra/Ahrtm3.1Bra
Tg(Six3-cre)69Frty/0
Not Specified
|
abnormal rod electrophysiology |
J:265123
|
|
increased retina apoptosis |
J:265123
|
|
photoreceptor outer segment degeneration |
J:265123
|
|
retina degeneration |
J:265123
|
|
retina outer nuclear layer degeneration |
J:265123
|
|
retina photoreceptor degeneration |
J:265123
|
|
short photoreceptor outer segment |
J:265123
|
Ahrtm3.1Bra/Ahrtm3.1Bra
Tg(Tek-cre)12Flv/0
B6.Cg-Ahrtm3.1Bra Tg(Tek-cre)12Flv
|
patent ductus venosus |
J:104388
|
Ahrtm3Bra/Ahrtm3Bra
involves: 129/Sv * C57BL/6J * DBA/2
|
decreased physiological sensitivity to xenobiotic |
J:94465
|
|
patent ductus venosus |
J:94465
|
Ahrtm4.1Bra/Ahrtm4.1Bra
involves: 129/Sv * C57BL/6
|
decreased physiological sensitivity to xenobiotic |
J:141978
|
|
enlarged heart |
J:141978
|
|
enlarged spleen |
J:141978
|
|
microvesicular hepatic steatosis |
J:141978
|
|
patent ductus venosus |
J:141978
|
|
small liver |
J:141978
|
Excel File
Analysis Tools